TOP 10 COMPANIES IN INFLUENZA DAIGNOSTICS MARKET
The influenza diagnostics market is expected to grow at a CAGR of 7.9% from 2020 to 2027 to reach at $1.17 billion by 2027. Influenza which is commonly known as “the flu”, is an infectious disease caused by an influenza virus. It is spread in all population more specifically in people with weak immune response. […]
Read More..Top 10 Companies in Infectious Disease Diagnostics Market
Infectious disease diagnostics comprises of various diagnostics technologies and platforms used by healthcare professionals to detect and diagnose diseases causing pathogens in human samples, including serum, blood, urine, throat swabs, and stool. It enables healthcare professionals for early diagnosis of the diseases and serves the patient population with better care management in less time and […]
Read More..Top 10 Companies in In Vitro Diagnostics Market | IVD Market
Growth of global IVD market is driven by rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments and automation in laboratories, and growing adoption of personalized medicine and point-of-care testing. Development of condition-specific markers and tests and growing demand for IVD products in emerging […]
Read More..TOP 10 COMPANIES IN DIGITAL TWIN MARKET
The global digital twin market is expected to grow at a CAGR of 38.1% from 2019 to reach $30.1 billion by 2025 where Asia Pacific Digital twin market is expected to grow at the highest CAGR. A digital twin is a virtual replica of a physical entity and is created by transmitting data generated from […]
Read More..TOP 10 COMPANIES IN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET
The global point of care (POC) molecular diagnostics market is expected to grow at a CAGR of 13.2% from 2019 to 2027 to reach at $2.39 billion by 2027 POC molecular diagnostics include portable devices and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. […]
Read More..Top 10 Companies in Real World Evidence Solutions market
With the growing need to achieve better value for healthcare, the importance of real-world evidence (RWE) as a decision-making tool and an important part of drug development and commercialization has also raised. Pharma and biopharma companies now recognize the need to get a better understanding and stronger evidence of product performance, clinical value and cost […]
Read More..Top 10 Companies in Point of Care Diagnostics Market
With the growing need for early disease diagnosis and improved patient outcomes, in-vitro diagnostics is shifting from centralized laboratories to decentralized point-of-care (POC) testing. POC testing is gaining traction as it enables rapid detection of analytes near to the patient, which facilitates quick medical decisions and better disease diagnosis, monitoring, and management. The global point […]
Read More..TOP 10 COMPANIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
The global antimicrobial susceptibility testing market is expected to grow at a CAGR of around 6.1% from 2019 to 2027 to reach at $5.09 billion by 2027. Susceptibility testing is used in the determination of the antimicrobials inhibiting the growth of the bacteria or fungi causing a specific infection. The aim of antimicrobial susceptibility testing […]
Read More..TOP 10 COMPANIES IN FLOW CYTOMETRY MARKET
The Global Flow Cytometry Market is expected to grow at a CAGR of 8.2% from 2019 to 2027 to reach at $6.36 billion by 2027. Flow cytometry is a widely used method for analyzing cell size & volume, assessing the purity of isolated subpopulations, characterizing & defining different cell types in a heterogeneous cell population, […]
Read More..TOP 10 COMPANIES IN CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET
The clinical trial materials and supplies market is expected to grow at a CAGR of 6% from 2019 to reach $25.9 billion by 2025. Clinical trials have a vigorous supply chain management of the drugs considering the stringency of the regulations and the availability of the infrastructure for the efficient execution. The drug manufacturers and […]
Read More..